Back to Search
Start Over
International Journal of Dermatology
- Source :
- Repositório Institucional da UFBA, Universidade Federal da Bahia (UFBA), instacron:UFBA
- Publication Year :
- 2003
-
Abstract
- Texto completo: acesso restrito. p. 203–207 Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-01-13T13:41:46Z No. of bitstreams: 1 André Báfica.pdf: 242239 bytes, checksum: 11179b434c51c965c7444dc03b6fe533 (MD5) Approved for entry into archive by Flávia Ferreira (flaviaccf@yahoo.com.br) on 2014-11-28T15:40:33Z (GMT) No. of bitstreams: 1 André Báfica.pdf: 242239 bytes, checksum: 11179b434c51c965c7444dc03b6fe533 (MD5) Made available in DSpace on 2014-11-28T15:40:33Z (GMT). No. of bitstreams: 1 André Báfica.pdf: 242239 bytes, checksum: 11179b434c51c965c7444dc03b6fe533 (MD5) Previous issue date: 2003 Background American cutaneous leishmaniasis is characterized by single or multiple ulcerations. Cytokines, among other factors, have been shown to influence lesion development and tumoral necrosis factor-alpha is a major cytokine implicated in pathogenesis of ulcers. Observations We tested oral pentoxifylline, a known tumoral necrosis factor-alpha inhibitor, at doses of 400 mg (2–3x/day), associated to N-methylglucamine antimoniate (15 mg/kg/day) in two patients with American cutaneous leishmaniasis unresponsive to antimonial drugs. We observed a satisfactory response with quick cure of skin lesions of these patients. Conclusions Our results suggest that oral pentoxifylline in association to N-methylglucamine antimoniate should be consider in refractory cutaneous leishmaniasis patients.
- Subjects :
- Leishmaniasis, Cutaneous
Pentoxifylline
Ulcer
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Repositório Institucional da UFBA, Universidade Federal da Bahia (UFBA), instacron:UFBA
- Accession number :
- edsair.od......3056..2dfb49962c015303786991ec22e93700
- Full Text :
- https://doi.org/10.1046/j.1365-4362.2003.01868.x